NewsRx

Search our medical news database

ZOLL Medical Corporation

ZOLL Medical Corporation Announces Agreement To Purchase Assets of Alsius Corporation

Published in Drug Week, March 13th, 2009

ZOLL Medical Corporation (Nasdaq GS: ZOLL) announced that it has signed an agreement with Alsius Corporation (Nasdaq: ALUS) under which ZOLL, through a wholly-owned subsidiary, will purchase from Alsius substantially all the assets constituting Alsius’s intravascular temperature management device business for a purchase price of twelve million dollars. The assets to be acquired include the intellectual property relating to the business, other intangibles, inventories and fixed assets. ZOLL will, as part of this agreement, assume warranty obligations relating to Alsius’s installed base of products. ZOLL plans to consolidate the operations of the acquired business at its facilities in...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Drug Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook